Insight Molecular Diagnostics Inc. Common Stock logo

Insight Molecular Diagnostics Inc. Common Stock

IMDX • NASDAQ • Stock Fundamentals

Insight Molecular Diagnostics Inc. Common Stock is a in vitro & in vivo diagnostic substances company trading on NASDAQ, led by CEO Joshua Riggs, with a market cap of $196.6M.

Market Cap$196.6M
Employees49.0
CEOJoshua Riggs
CountryUnited States of America
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026
View report
Next EarningsAug 10, 2026 · in 2 monthsAfter Market Close · Q2 2026
Income StatementBalance SheetCash FlowSegments

Financials

Based on Q1 2026 filing

View all metrics
Insight Molecular Diagnostics Inc. Common Stock logo

Insight Molecular Diagnostics Inc. Common Stock FAQ

Common questions about Insight Molecular Diagnostics Inc. Common Stock

Insight Molecular Diagnostics Inc. Common Stock (IMDX) has a market capitalization of $196.6M and trades on NASDAQ.

Insight Molecular Diagnostics Inc. Common Stock has approximately 49 employees.